CELLMED 2021 KCI Impact Factor : 0.02

Korean | English

eISSN : 2233-8985

Home > Explore Content > All Issues > Article List

2022, Vol.12, No.3

  • 1.

    Effect of Sharbat Afsantīn in Poly Cystic Ovarian Disease - An Open Observational Study

    Zainab Zubair , Ismath Shameem , Wajeeha Begum | 2022, 12(3) | pp.10~10 | number of Cited : 0
    Abstract PDF
    Objective: The objective of the study was to evaluate the effect of Sharbat Afsantīn in Polycystic Ovarian Disease. Methods: An open observational study was carried out in the Department of Ilmul Qabalat wa Amraze Niswan. Diagnosed cases(n=30) of PCOD were included in the study. Patients with thyroid dysfunction, systemic diseases, on hormonal treatment in last three months, pregnancy and lactation were excluded. Research drug (Sharbat Afsantīn) was administered orally in a dose of 25ml twice daily for 15 days/cycle for three consecutive cycles. Outcome measures were, changes in subjective parameters (duration of cycle, duration and amount of flow and weight reduction) and objective parameters {pictorial blood loss assessment chart (PBAC) score, basal metabolic index (BMI), modified Ferriman Gallwey (mFG) score, acanthosis nigricans scale and pelvic ultrasonography}. Data were analyzed using paired Student ‘t’ test. Results: Changes in duration of cycle, duration and amount of flow were achieved in 83.3%, 50% and 40% patients respectively and weight reduction in 30% patients. Changes in PBAC score and BMI were achieved in 50% and 30% patients respectively and 30% patients showed normal findings on pelvic ultrasonography. Conclusion: Sharbat Afsantīn can be used as an alternate remedy in PCOD patients, as it has significant effect to regularize menstruation by reduction in BMI and probably by improving insulin resistance in PCOD. No adverse effect of Sharbat Afsantīn was noted during the trial.
  • 2.

    Eclectic rehabilitation for bell’s palsy: A case report

    Jyoti Jha , Huma Khan , Sahar Zaidi | 2022, 12(3) | pp.11~11 | number of Cited : 0
    Abstract PDF
    Bell’s Palsy is one of the most common mononeuropathies or disorders affecting a single nerve and is associated with facial nerve weakness and paralysis. Though self-limiting the disorder may leave its long-lasting residual manifestations in the form of abnormal facial symmetry, inability to close the eyes, and other poor outcomes leading to disability and impairment in societal functioning among patients. Treatment strategies include pharmacological, surgical, and therapeutic options and to limit the long-term devastating effects therapeutic options play a vital role. Physiotherapeutic techniques have been widely used among patients with Bell’s Palsy but not all techniques are performed in combination. One is compared with the other and also for short durations. We planned this study to see the outcome of combined techniques available in Physiotherapy on a patient with long-term follow-up. This is a case of 38 years old male patient diagnosed with right-sided bell palsy who received 7 weeks of rehabilitation in the form of electrotherapy, facial exercises, facial PNF, massage, and education on eye care. The implementation of 7 weeks of physiotherapeutic rehabilitation led to improved facial functions and a reduction in the level of disability in the patient.
  • 3.

    The impact of an Unani Formulation in unexplained Secondary Infertility: A Case Report

    Sumaiya Mohammed Sabir Siddiqui , Ismath Shameem | 2022, 12(3) | pp.12~12 | number of Cited : 0
    Abstract PDF
    With a prevalence incidence of 8 % to 37%, unexplained infertility (Uqr) is by definition empiric because it does not address a particular defect or functional deficits. Couples with unexplained infertility have a higher than zero chance of becoming pregnant without treatment, but it is less likely than couples who are fertile. The ingredients in the Unani formulation, are baikh asgand (Withania somnifera Dunal), baikh piyabansa (Barleria prionitis Linn), gule dhawa (Anogeissus latifolia), and gule nilofar (Nymphaea alba Linn), were used to treat unexplained secondary infertility, possess the characteristics of muqawwi bah (Aphrodisiac), muqawwi Rahim (Uterotonic), muwallid-i-mani (ovulation-inducing), and mughalliz-i-mani (an agent which increases the viscosity of semen) beginning from the fifth day of the last menstrual cycle for five days with milk. The first cycle of treatment led to the conception of the women.
  • 4.

    Synergistic effect of Samulnori performance and Ajaeng playing on music therapy (https://youtu.be/hYN9vG0278o)

    Kyung-Ja Ko , HYUN-YONG CHO | 2022, 12(3) | pp.13~13 | number of Cited : 0
    Abstract PDF
    The aim of this study was to evaluate the synergistic effect of Samulnori and Ajaeng combination in music therapy. Samulnori is the Korea’s most successful traditional music. The Ajaeng, Korean traditional string instrument, generally plays the bass part in ensemble music. However, we have tried a new kind of musical style. (As you can see in the Youtube, https://youtu.be/QHIciJTTY0w). Samulnori and Ajaeng combination of our style have not been tried by any other musicians in Korea. Results from this study showed that Samulnori-induced excitation and Ajaeng-induced dynamics probably contributed to the synergistic effect of Samulnori and Ajaeng.
  • 5.

    Experiential treatment of ankylosing spondylitis using Ortho-Cellular Nutrition Therapy (OCNT)

    Kyung Sin Baek | 2022, 12(3) | pp.14~14 | number of Cited : 0
    Abstract PDF
    Currently, a 70-year-old woman started suffering from S.I joint pain from 1973 and had severe pain in the S.I joint, wrist, and elbow from 1975 to 1977, and was diagnosed with spinal tuberculosis at a general hospital. From 1978 to 1987, she suffered from chronic fatigue and insomnia, and since January 1, 1988, she was unable to get up while lying down, suffering from whole body joint, muscle pain, and fibromyalgia. In May 1989, she was also diagnosed with ankylosing spondylitis through genetic testing at the Catholic St. Mary's Hospital Rheumatology Department in Korea, and was treated with sulfasalazine, analgesic, and immunosuppressant, methotrexate, for 12 years until 1999, but none of the drugs eliminated the pain. She was hospitalized and discharged repeatedly, and continued to receive salt water poultice and exercise therapy at home, but was unable to move at all. In 2000, after biologic treatment with Remicade injection (Remsima®), she was able to walk and move, and after that, she was continuously prescribed biologics. From 2015 to 2019, Enbrel® (Etanercept) injection was prescribed once a week, but the symptoms such as severe pain (joint and muscle, fibromyalgia), scleroderma, Sjogren's syndrome (dryness of eyes, nose and mouth), difficulty swallowing, chronic fatigue, and stiff body appeared. Around January 2018, hepatic indicators were high and lymphocytes became enlarged. However, most serious injuries were highly improved after the OCNT combination therapy using active phytonutrients, anthocyanin-fucoidan nanocomplex. Therefore, for patients with such experiences, OCNT treatment is proposed as an alternative.